EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aspen Pharmacare Holdings's enterprise value is $6,125 Mil.
Aspen Pharmacare Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $437 Mil. Therefore, Aspen Pharmacare Holdings's EV-to-EBITDA for today is 14.01.
The historical rank and industry rank for Aspen Pharmacare Holdings's EV-to-EBITDA or its related term are showing as below:
APNHY'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.25 Med: 15.85 Max: 28.04
Current: 14.73
During the past 13 years, the highest EV-to-EBITDA of Aspen Pharmacare Holdings was 28.04. The lowest was 7.25. And the median was 15.85.
APNHY's EV-to-EBITDA is ranked worse than 53.68% of 706
companies
in the Drug Manufacturers industry
Industry Median: 13.745
vs APNHY: 14.73
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-18), Aspen Pharmacare Holdings's stock price is $11.59.
Aspen Pharmacare Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.655. Therefore, Aspen Pharmacare Holdings's PE Ratio for today is 17.69.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Aspen Pharmacare Holdings EV-to-EBITDA Historical Data
The historical data trend for Aspen Pharmacare Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Aspen Pharmacare Holdings Annual Data
Trend
Jun14
Jun15
Jun16
Jun17
Jun18
Jun19
Jun20
Jun21
Jun22
Jun23
EV-to-EBITDA
14.49
13.50
10.18
7.34
10.34
Aspen Pharmacare Holdings Semi-Annual Data
Dec13
Jun14
Dec14
Jun15
Dec15
Jun16
Dec16
Jun17
Dec17
Jun18
Dec18
Jun19
Dec19
Jun20
Dec20
Jun21
Dec21
Jun22
Dec22
Jun23
EV-to-EBITDA
10.18
-
7.34
-
10.34
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Pharmacare Holdings EV-to-EBITDA Distribution
For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aspen Pharmacare Holdings's EV-to-EBITDA falls into.
Aspen Pharmacare Holdings's current Enterprise Value is $6,125 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aspen Pharmacare Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $437 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Aspen Pharmacare Holdings's PE Ratio for today is calculated as:
Aspen Pharmacare Holdings's share price for today is $11.59.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aspen Pharmacare Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.655.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Aspen Pharmacare Holdings EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APNHY has been successfully added to your 